Emsam
selegiline transdermal system
Treatment for DepressionSomerset Files Response to Emsam Action Letter
FDA Considers Response Complete - Issues PDUFA Review Date
PITTSBURGH and CORONA, Calif., June 16, 2005 -- Mylan Laboratories Inc. and Watson Pharmaceuticals, Inc. , today announced that Somerset Pharmaceuticals, Inc. has submitted a response to the United States Food and Drug Administration's Action letter, dated January 30, 2004, related to Emsam (selegiline transdermal system). The FDA has accepted Somerset's May 26, 2005 response as complete and has issued a Prescription Drug User Fee Act (PDUFA) goal date for these submissions of November 27, 2005.
Somerset Pharmaceuticals, Inc. is a joint venture between Mylan and Watson. Emsam is an investigational monoamine oxidase inhibitor administered transdermally for acute and maintenance treatment of patients with major depressive disorder.
About Mylan Laboratories Inc.
Mylan Laboratories Inc. is a leading pharmaceutical company with
three principal subsidiaries, Mylan Pharmaceuticals Inc., Mylan
Technologies Inc. and UDL Laboratories Inc., that develop, license,
manufacture, market and distribute an extensive line of generic and
proprietary products.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, CA, is a
leading specialty pharmaceutical company that develops,
manufactures, markets, sells and distributes brand and generic
pharmaceutical products. Watson pursues a growth strategy combining
internal product development, strategic alliances and
collaborations and synergistic acquisitions of products and
businesses.
Related Articles:
Emsam Approved - Bristol-Myers Squibb Company/Somerset Pharmaceuticals, Inc. - Treatment for Major Depressive Disorder - February 28, 2006
Mylan Laboratories and Watson Pharmaceuticals Announce Receipt of "Approvable" Letter for Emsam - February 2, 2004
New Drug Applications Archive
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2005: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2004: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
